{
  "ticker": "EBR",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02976922",
  "id": "02976922",
  "pages": 2,
  "price_sensitive": true,
  "date": "20250805",
  "time": "0921",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250805/pdf/06mjvvv8jrbqb6.pdf",
  "summary": "### Material Information Summary:\n- **NTAP Approval**: U.S. CMS granted maximum NTAP reimbursement for EBR\u2019s WiSE\u00ae System (up to **US$41,145** per device, in addition to DRG payments).  \n- **Effective Date**: Reimbursement begins **1 October 2025**, aligning with limited market release.  \n- **Duration**: NTAP valid for **3 years**; EBR will petition CMS in Year 2 for full DRG coverage.  \n- **TPT Approval Pending**: Transitional Pass-Through (TPT) payment for outpatient settings expected by **1 October 2025** (preliminary approval already recommended).  \n\n**Impact**: Enhances commercialization viability and hospital adoption of WiSE System in the U.S., materially improving revenue potential.  \n\n*Omitted: Forward-looking statements, operational details, historical context.*",
  "usage": {
    "prompt_tokens": 1935,
    "completion_tokens": 181,
    "total_tokens": 2116,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-08-04T23:39:11.294331"
}